Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

Breaking Down Barriers to Clinical Trial Diversity - Health Equity Summit

On June 22nd, The Atlantic hosted its Health Equity Summit, which focused on what the health care system is doing to combat inequities across race, age and gender to improve health outcomes for all Americans.

As part of this event, Amgen held a conversation to explore diversity in clinical trials and how to break down barriers and increase participation in cancer clinical trials among historically underrepresented communities.

Watch as Dr. Ponda Motsepe-Ditshego, global executive medical platform lead, Bone & Nephrology at Amgen and Dr. Marya Shegog, Health Equity and Diversity Coordinator at the Lazarex Cancer Foundation discuss the strides made to increase representation and the work that still needs to be done to help address barriers to greater diversity.

Find out more about Amgen:
https://www.amgen.com/

Find Amgen on the Web:
Facebook: https://bit.ly/35Xf09E
Instagram: https://bit.ly/2SYnTKJ
Twitter: https://bit.ly/2SW2cLq
LinkedIn: https://bit.ly/2xWbS17

Видео Breaking Down Barriers to Clinical Trial Diversity - Health Equity Summit канала Amgen
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
30 июня 2021 г. 1:41:29
00:08:08
Amgen
Теги
Правообладателям
Жалоба
Комментарии
Другие видео канала
The Challenges in Manufacturing BiologicsThe Challenges in Manufacturing BiologicsApplying the Power of Omics to Research and DevelopmentApplying the Power of Omics to Research and DevelopmentAmgen Science - Biotechnology for the Next DecadeAmgen Science - Biotechnology for the Next DecadeAmgen’s Virtual Health Equity 2021 SummitAmgen’s Virtual Health Equity 2021 SummitRegulation of Osteoclast ActivityRegulation of Osteoclast ActivityThe Next Generation of Biomanufacturing at AmgenThe Next Generation of Biomanufacturing at AmgenThe Hunt for New Checkpoint Inhibitors - Amgen ScienceThe Hunt for New Checkpoint Inhibitors - Amgen ScienceThe Human Data Project: Precision Medicine and Its Impact on Patient OutcomesThe Human Data Project: Precision Medicine and Its Impact on Patient OutcomesFast Facts About Efficacy of Biosimilars – Amgen ScienceFast Facts About Efficacy of Biosimilars – Amgen ScienceFast Facts About the Quality of Biosimilars – Amgen ScienceFast Facts About the Quality of Biosimilars – Amgen ScienceEvery Patient Counts, Every Story Matters: Jeff and Dr. Ravi SalgiaEvery Patient Counts, Every Story Matters: Jeff and Dr. Ravi SalgiaFast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen ScienceFast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen ScienceEvery Patient Counts, Every Story Matters: Nancy and BennettEvery Patient Counts, Every Story Matters: Nancy and BennettEvery Patient Counts, Every Story Matters: Rod Gilmore and Janet GilmoreEvery Patient Counts, Every Story Matters: Rod Gilmore and Janet GilmoreInnovation Squared: Ep 8 | Obliterating ObstructionsInnovation Squared: Ep 8 | Obliterating ObstructionsAmgen Supports U.S. Military VeteransAmgen Supports U.S. Military VeteransAmgen's Ohio GroundbreakingAmgen's Ohio GroundbreakingThe Race to Get New Medicines to PatientsThe Race to Get New Medicines to PatientsWhat is it Like Living with Severe Asthma?What is it Like Living with Severe Asthma?Innovation Squared: Ep 7 | Changing the Status QuoInnovation Squared: Ep 7 | Changing the Status Quo
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала